RavenQuest BioMed Provides Indigenous Populations with Turnkey Cannabis Solutions


Ryan Allway

January 18th, 2018

Exclusive, News, Top News


Canada’s cannabis industry is expected to reach $22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis this year. While there are already over 70 licensed producers, there is one segment of the market that remains relatively underserved – Canada’s Indigenous Peoples. These communities could eventually account for a large portion of the overall market with unique benefits.

RavenQuest BioMed Inc. (CSE: RQB) aims to provide Indigenous populations with unique turnkey solutions with respect to the licensing, engineering, construction and operation of cannabis cultivation facilities.

Unique Turnkey Solutions

RavenQuest BioMed’s CEO, George Robinson, has helped more than ten producers of medical cannabis become licensed by Health Canada. With RavenQuest, Mr. Robinson plans to expand these activities to help Indigenous Peoples secure licenses and setup top-tier licensed cannabis production operations using turnkey solutions. The company has since added many highly-qualified executives and advisors focused on this unique niche.

The company’s turnkey solutions include its Orbital Gardens, which help maximize the number of grams of cannabis flower or oil that can be generated per square foot of grow space. With three-dimensional grow capacity, the technology stacks three-high and two-wide to provide maximum grow space with full automation and minimal visits into the grow rooms. Management believes that this makes it one of the most efficient grow technologies on the market.

In addition to its technology and management services, the company recently acquired an aspiring licensed producer of its own that has received a pre-license inspection letter from Health Canada. The completed facility is expected to consist of a 35,500 sq. ft. facility that is capable of producing about 7,000 kilograms of cannabis flower per year. The licensing process is being handled by the Services Group, which has a 100% success rate for applicants.

Indigenous Peoples Focus

RavenQuest BioMed’s focus on Indigenous Peoples is unique among publicly-traded cannabis companies. Under the guidance of Mr. Dwight (Bill) Robinson, the company aims to identify, cultivate, and deepen relationships with Indigenous Peoples. Mr. Robinson served with the RCMP for 34 years in communities across Canada and worked closely with Indigenous Peoples communities.  

In November, the company entered into first first major Indigenous People’s agreement with Fort McMurray #468 First Nation to provide its turnkey cannabis industry solution. The agreement calls for cannabis license application development, architecture and engineering of a 24,000 sq. ft. licensed cannabis production facility, and strategic planning for entry into the industry.

“Through our environmentally-sustainable production model and end-to-end solutions, we intend to emerge as the trusted provider of choice for Indigenous Peoples’ cannabis industry partnerships across Canada,” said RavenQuest CEO George Robinson. “The mutually beneficial agreement represents an important step in this direction. We are extremely excited to enter into this unique partnership with Fort McMurray #468 First Nation.”

The company also created the Indigenous People Cannabis Association, which has grown to include over 70 members in recent months. In total, management expects that about one-fifth of total cannabis canopy will be allocated to indigenous peoples over the coming years, making it a very large and important part of the country’s medical and adult-use cannabis industry, as well as a great investment opportunity for the company and its shareholders.

Looking Ahead

RavenQuest BioMed Inc. (CSE: RQB) represents a unique investment opportunity in Canada’s burgeoning cannabis industry. With a focus on indigenous peoples, the company provides consulting services and innovative technologies designed to maximize results. The company also aims to navigate its own AGB project through licensing and approval, which helps validate its management services and could become a proving ground for its technology.

For more information, visit the company’s website at www.rqbglobal.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading